Life sciences · Journal article
Particle & Particle Systems Characterization · October 31, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
ABSTRACT The inherent complexity of cancer treatment limits the efficacy of conventional therapies, which frequently cause damage to healthy tissues. This limitation has driven the development of more localized strategies like minimally invasive photothermal therapy (PTT) using near‐infrared lasers. Due to their exceptional optical characteristics, gold nanorods (AuNRs) emerge as a leading material in this field, yet the heavy cytotoxicity of the surfactant cetyltrimethylammonium bromide (CTAB) remains a major biomedical barrier. To overcome the cytotoxicity challenges and introduce a biofunctional surface, we developed multifunctional gold nanorods by replacing toxic CTAB with a biorelevant bovine serum albumin (BSA) and hyaluronic acid (HA) conjugate synthesized via the Maillard reaction. This functionalization creates a biorelevant and multimodal coating that eliminates toxicity while protecting colloidal stability. Characterization confirmed that the AuNRs retained their structural and optical integrity after functionalization. In vitro assays in L929 and MCF‐7 cells supported the elimination of surfactant‐induced cytotoxicity, showing good cytocompatibility. Furthermore, under 808 nm laser irradiation, the developed BSA:HA@AuNRs demonstrated the destruction of MCF‐7 cancer cells and showed great promise for PTT applications.